{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:45:46Z","timestamp":1792017946900,"version":"4.4.0"},"reference-count":27,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"10","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Oncol Pract"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Men with prostate cancer face considerable cardiovascular (CV) comorbidity. Androgen deprivation therapy (ADT) and androgen receptor pathway inhibitors (ARPIs) elevate this risk, yet no prostate-specific CV monitoring tools exist. Clinicians rely on general calculators such as the American Heart Association (AHA)\/American College of Cardiology (ACC) atherosclerotic cardiovascular disease (ASCVD) score, which remain unvalidated in this setting. The purpose of this study is to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>\n                      This was a post hoc analysis of sixty-three men with localized high-risk prostate cancer treated with 6 months of preoperative ADT plus apalutamide with or without abiraterone on a trial (ClinicalTrials.gov identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03279250\">NCT03279250<\/jats:ext-link>\n                      ). ASCVD risk and metabolic syndrome (MetS) Z scores were calculated at baseline and the end of treatment using AHA\/ACC and MetS calculators.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>After 6 months of ADT plus ARPI, the median ASCVD risk score increased modestly (+0.95), with 21% exhibiting a clinically significant increase (\u22652.5%). This was primarily driven by increases in total cholesterol (median, 182-211) and low-density lipoprotein (median, 101-122), whereas blood pressure did not have a clinically significant change. Five patients experienced a major adverse CV event, yet only one had a clinically significant increase in ASCVD risk score. Only 28% of patients experienced an increase in MetS risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>After 6 months of ADT plus ARPI, men with prostate cancer showed worsening lipid profiles and 21% had worsening of their CV risk based on general population tools. These findings highlight the unmet need to develop prostate cancer\u2013specific CV risk assessment tools.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/op-25-00506","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:59:07Z","timestamp":1762549147000},"page":"1854-1860","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone Therapy"],"prefix":"10.1200","volume":"22","author":[{"given":"Neha","family":"Venkatesh","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6054-5585","authenticated-orcid":true,"given":"Pankaj Kumar","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar S.","family":"Mukhida","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"},{"name":"Division of Diagnostic Imaging, Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabir","family":"Grewal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0900-0923","authenticated-orcid":true,"given":"Ana","family":"Aparicio","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"Pilie","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5208-7732","authenticated-orcid":true,"given":"Sumit K.","family":"Subudhi","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Corn","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7359-7114","authenticated-orcid":false,"given":"Ashwin","family":"Sachdeva","sequence":"additional","affiliation":[{"name":"Division of Cancer Sciences, Genitourinary Cancer Research Group, University of Manchester, Manchester, United Kingdom"},{"name":"Department of Surgery, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3090-1929","authenticated-orcid":true,"given":"Monica","family":"Desai","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6806-1294","authenticated-orcid":true,"given":"Bilal A.","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amado J.","family":"Zurita","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4811-4547","authenticated-orcid":true,"given":"Debanjan","family":"Pain","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3852-8199","authenticated-orcid":true,"given":"Justin R.","family":"Gregg","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0713-471X","authenticated-orcid":true,"given":"Daniel E.","family":"Frigo","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"},{"name":"Division of Diagnostic Imaging, Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Logothetis","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6505-8308","authenticated-orcid":true,"given":"Pavlos","family":"Msaouel","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6757-6480","authenticated-orcid":true,"given":"Efstratios","family":"Koutroumpakis","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4153-205X","authenticated-orcid":true,"given":"Andrew W.","family":"Hahn","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.19568"},{"key":"e_1_3_7_4_2","first-page":"33","article-title":"Cardiometabolic healthcare for men with prostate cancer: An MD Anderson Cancer Center experience","volume":"9","author":"Hahn AW","year":"2023","unstructured":"Hahn AW, Thoman W, Koutroumpakis E, et al: Cardiometabolic healthcare for men with prostate cancer: An MD Anderson Cancer Center experience. Cardiooncology 9:33, 2023","journal-title":"Cardiooncology"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0070"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000714"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.04.015"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.313046"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003721"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-24-0195"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae308"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2023.10.010"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.1549"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.012519"},{"key":"e_1_3_7_15_2","first-page":"11820","article-title":"Optimizing outcomes in men with prostate cancer: The cardiovascular event lowering (CaELo) pathways","volume":"31","author":"Crawford DE","year":"2024","unstructured":"Crawford DE, Albala D, Garnick MB, et al: Optimizing outcomes in men with prostate cancer: The cardiovascular event lowering (CaELo) pathways. Can J Urol 31:11820-11825, 2024","journal-title":"Can J Urol"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1920"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.03.009"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2013.10.006"},{"key":"e_1_3_7_19_2","unstructured":"American College of Cardiology. \u201cASCVD risk estimator.\u201d https:\/\/tools.acc.org\/ldl\/ascvd_risk_estimator\/#!\/calulate\/estimator\/"},{"key":"e_1_3_7_20_2","unstructured":"Gurka MJ Deboer M. Metabolic Syndrome Severity Calculator. https:\/\/metscalc.org\/metscalc\/"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.01.014"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.102107"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkad005"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2024.04.004"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00848-6"},{"key":"e_1_3_7_26_2","article-title":"Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular toxicity from androgen deprivation therapy in men with prostate cancer","volume":"42","author":"Patel SA","year":"2024","unstructured":"Patel SA, Marra A, Switchenko JM, et al: Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular toxicity from androgen deprivation therapy in men with prostate cancer. J Clin Oncol 42, 2024 (suppl 4; abstr 312)","journal-title":"J Clin Oncol"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-0803"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00870-8"}],"container-title":["JCO Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/OP-25-00506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:59:39Z","timestamp":1792015179000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/OP-25-00506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1200\/OP-25-00506"],"URL":"https:\/\/doi.org\/10.1200\/op-25-00506","relation":{},"ISSN":["2688-1527","2688-1535"],"issn-type":[{"value":"2688-1527","type":"print"},{"value":"2688-1535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"2025-05-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}